# A network meta‐analysis of efficacy and safety of first‐line and second‐line therapies for the management of metastatic renal cell carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-network-meta-analysis-of-efficacy-and-safety-of-first-line-and-second-line/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ji Haeng Heo,Chanhyun Park,Somraj Ghosh,Sun‐Kyeong Park,Marko Zivkovic,Karen L. Rascati |
| Citations | 27 |
| DOI | 10.1111/jcpt.13282 |
| Fields | Decision Sciences,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jcpt.13282 |
| OpenAlex ID | https://openalex.org/W3095918203 |
| PMID | 33112003 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Somraj Ghosh](https://scholariq.org/researchers/somraj-ghosh/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.